Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism

Alexandre A. Jácome, Aki Ohinata, Armeen Mahvash, Michael J. Overman, Bryan Kee, David Fogelman, Van K. Morris, Benny Johnson, Nicole D. Rothschild, Robert A. Wolff, Cathy Eng

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism'. Together they form a unique fingerprint.

Medicine & Life Sciences